Aquestive Therapeutics, Inc. provided earnings guidance for the full year of 2022. For the period, the company expects Total revenues of approximately $42 million to $47 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.42 USD | +4.76% |
|
-9.70% | +19.80% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.80% | 210M | |
+54.61% | 815B | |
+44.25% | 654B | |
-6.33% | 354B | |
+20.62% | 337B | |
+10.44% | 302B | |
+18.45% | 247B | |
+2.09% | 229B | |
+13.03% | 219B | |
+8.61% | 171B |
- Stock Market
- Equities
- AQST Stock
- News Aquestive Therapeutics, Inc.
- Aquestive Therapeutics Provides Earnings Guidance for the Full Year 2022